IL158171A0 - Compositions and methods for cell separation - Google Patents

Compositions and methods for cell separation

Info

Publication number
IL158171A0
IL158171A0 IL15817102A IL15817102A IL158171A0 IL 158171 A0 IL158171 A0 IL 158171A0 IL 15817102 A IL15817102 A IL 15817102A IL 15817102 A IL15817102 A IL 15817102A IL 158171 A0 IL158171 A0 IL 158171A0
Authority
IL
Israel
Prior art keywords
methods
cell separation
compositions
reagents
high yield
Prior art date
Application number
IL15817102A
Other languages
English (en)
Original Assignee
Bioergonomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioergonomics Inc filed Critical Bioergonomics Inc
Publication of IL158171A0 publication Critical patent/IL158171A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ecology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cell Separators (AREA)
  • Processing Of Solid Wastes (AREA)
IL15817102A 2001-04-10 2002-03-07 Compositions and methods for cell separation IL158171A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28282301P 2001-04-10 2001-04-10
PCT/US2002/007079 WO2002083262A1 (fr) 2001-04-10 2002-03-07 Compositions et methodes de separation cellulaire

Publications (1)

Publication Number Publication Date
IL158171A0 true IL158171A0 (en) 2004-03-28

Family

ID=23083276

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15817102A IL158171A0 (en) 2001-04-10 2002-03-07 Compositions and methods for cell separation
IL158171A IL158171A (en) 2001-04-10 2003-09-30 Compositions, kits and methods for cell separation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158171A IL158171A (en) 2001-04-10 2003-09-30 Compositions, kits and methods for cell separation

Country Status (12)

Country Link
US (2) US7160723B2 (fr)
EP (2) EP1377353A4 (fr)
JP (2) JP4212898B2 (fr)
CN (1) CN1327927C (fr)
AT (1) ATE493186T1 (fr)
AU (1) AU2002255678B2 (fr)
CA (1) CA2442577C (fr)
DE (1) DE60238801D1 (fr)
IL (2) IL158171A0 (fr)
MX (1) MXPA03009258A (fr)
RU (1) RU2292555C2 (fr)
WO (1) WO2002083262A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242520A1 (en) * 1997-09-06 2004-12-02 Mayo Foundation For Medical Education And Research, A Minnesota Corporation Expression of immonogenic substances
EP1377353A4 (fr) * 2001-04-10 2005-08-31 Bioergonomics Inc Compositions et methodes de separation cellulaire
US7316932B2 (en) * 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
DK1553832T3 (da) * 2002-09-27 2007-10-01 Bioe Inc Præparater og fremgangsmåder til celleseparering
EP1639099B1 (fr) 2003-06-27 2011-05-18 Université Laval Methode permettant d'isoler des cellules du cordon ombilical
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
EP1747265B1 (fr) * 2004-04-23 2011-04-20 BioE LLC Cellules précurseurs de plusieurs lignages
EP2019858B1 (fr) * 2006-04-17 2012-06-13 BioE LLC Différenciation des cellules progénitrices à lignées multiples en cellules épithéliales respiratoires
US7598089B2 (en) * 2006-04-19 2009-10-06 Bioe, Inc. Methods and compositions for separating cells
CN101484586A (zh) * 2006-05-02 2009-07-15 特拉科斯有限公司 检测移植物抗宿主疾病易感性或移植相关死亡率的方法和试剂
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
US20100081121A1 (en) * 2007-02-08 2010-04-01 Ge Healthcare Bio-Sciences Ab Media and method for cell separation
WO2008153802A1 (fr) * 2007-05-29 2008-12-18 Eusa Pharma, Inc. Traitement ex-vivo du cancer au moyen de psma et d'anticorps de psma
JP5210551B2 (ja) * 2007-06-19 2013-06-12 ベックマン コールター バイオメディカル リミテッド 赤血球標識用磁性粒子
WO2009015343A2 (fr) * 2007-07-25 2009-01-29 Bioe, Inc. Différenciation de cellules de progéniteur à multiples lignées en chondrocytes
US8834887B2 (en) * 2007-09-26 2014-09-16 National Cerebral And Cardiovascular Center Drug for suppressing pathogen occurring in vivo
WO2009143241A2 (fr) * 2008-05-21 2009-11-26 Bioe, Inc. Différenciation de cellules progénitrices de multiples lignées en cellules pancréatiques
RU2011105767A (ru) * 2008-08-04 2012-09-10 Синмед Рисёч Гмбх (At) Способ исследования, в частности количественного анализа, молекулярных маркеров, поглощенных из ткани макрофагами крови, которые повторно поступают из тканей в кровеносную систему
CN101885770B (zh) * 2009-05-12 2014-07-30 成都生物制品研究所有限责任公司 一种特异性结合cd15的全人源抗体及应用
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CA2807942C (fr) * 2010-08-10 2021-07-27 Ecole Polytechnique Federale De Lausanne Agents therapeutiques se liant aux erythrocytes
US20130288227A1 (en) * 2010-11-01 2013-10-31 Daniel P. Collins Methods and compositions for cell separation of blood tissues
CA2819260A1 (fr) 2010-12-15 2012-06-21 Cytosed, Inc. Agent d'immuno-sedimentation lie a un anticorps et procede d'isolement d'une cible a partir d'un echantillon a l'aide de celui-ci
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
DK2597153T3 (en) * 2011-11-25 2016-12-05 Miltenyi Biotec Gmbh Method for cell separation
US9970849B2 (en) 2014-01-21 2018-05-15 Stemcell Technologies Inc. Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
MX2016010835A (es) 2014-02-21 2017-07-11 Anokion Sa Terapeuticos dirigidos a la glucosa.
EP2985289A1 (fr) * 2014-08-14 2016-02-17 Miltenyi Biotec GmbH Déplétion des cellules de souris pour isolation générique de cellules humaines lors d'une xénotransplantation
EP3037170A1 (fr) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Procédé de séparation de cellules multitris
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
EP3638296A1 (fr) 2017-06-16 2020-04-22 The University Of Chicago Compositions et procédés d'induction d'une tolérance immunitaire
CN111235104A (zh) * 2020-03-30 2020-06-05 山东省立医院 一种孕妇外周血胎儿有核红细胞分离纯化方法及分离仪

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6048715A (en) * 1988-07-08 2000-04-11 Univ. Of British Columbia Two-phase partition affinity separation system and affinity separated cell-containing composition
US5397479A (en) * 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
US5514340A (en) * 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6146628A (en) * 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US5773224A (en) * 1996-02-12 1998-06-30 Grandics; Peter Immunoselection system for cell elution
JP4719326B2 (ja) 1996-08-15 2011-07-06 司 松元 赤血球の分画法
AU4101697A (en) 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
CA2278208C (fr) * 1997-01-24 2011-09-20 Asahi Medical Co., Ltd. Procede de separation des cellules
WO1998045413A1 (fr) * 1997-04-08 1998-10-15 Pall Corporation Procede de prelevement de cellules rares dans des produits sanguins
US6491917B1 (en) * 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6448075B1 (en) * 1999-05-28 2002-09-10 Stemcell Technologies Inc. Method for separating cells using immunorosettes
US7135335B2 (en) * 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
EP1377353A4 (fr) * 2001-04-10 2005-08-31 Bioergonomics Inc Compositions et methodes de separation cellulaire
US7855318B2 (en) * 2001-11-13 2010-12-21 U.S. Smokeless Tobacco Company Cloning of cytochrome P450 genes from Nicotiana
DK1553832T3 (da) 2002-09-27 2007-10-01 Bioe Inc Præparater og fremgangsmåder til celleseparering
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues

Also Published As

Publication number Publication date
US7476547B2 (en) 2009-01-13
EP1377353A1 (fr) 2004-01-07
EP1916297A2 (fr) 2008-04-30
IL158171A (en) 2012-09-24
RU2003132547A (ru) 2005-03-10
JP4212898B2 (ja) 2009-01-21
CA2442577A1 (fr) 2002-10-24
DE60238801D1 (de) 2011-02-10
US20030027233A1 (en) 2003-02-06
US7160723B2 (en) 2007-01-09
US20070154961A1 (en) 2007-07-05
EP1377353A4 (fr) 2005-08-31
RU2292555C2 (ru) 2007-01-27
EP1916297B1 (fr) 2010-12-29
WO2002083262A1 (fr) 2002-10-24
AU2002255678B2 (en) 2008-05-08
ATE493186T1 (de) 2011-01-15
EP1916297A3 (fr) 2008-05-14
CA2442577C (fr) 2011-08-30
CN1658940A (zh) 2005-08-24
JP2004526452A (ja) 2004-09-02
CN1327927C (zh) 2007-07-25
JP2008289506A (ja) 2008-12-04
MXPA03009258A (es) 2004-11-12

Similar Documents

Publication Publication Date Title
IL158171A0 (en) Compositions and methods for cell separation
EP1553832A4 (fr) Compositions et procedes de separation de cellules
AU2001249386A1 (en) Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
EP0918848A4 (fr) Procedes de traitement de cancers et d'infections par pathogenes au moyen de cellules presentatrice d'antigenes chargees d'arn
AU2001298049A1 (en) Hla class i and ii binding peptides and their uses
WO2004111075A3 (fr) Compositions et procedes utilisant des polypeptides a cadre de lecture differents dans le traitement du cancer et de maladies infectieuses
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
AU6380001A (en) Porous ferro- or ferrimagnetic glass particles for isolating molecules
WO2005048957A3 (fr) Nouveaux sites d'insertion dans des vecteurs de variole
WO2004065015A3 (fr) Separateur magnetique
WO2003020877A3 (fr) Coloration et tri de genomes et de chromosomes au moyen de polyamides specifiques de sequences
AU2002249531A1 (en) Immunotherapy based on dendritic cells
WO2005085440A8 (fr) Procede pour concentrer et/ou separer de l'adn procaryote au moyen d'une proteine qui se lie de maniere specifique a de l'adn non methyle contenant des motifs cpg
EP2117592A4 (fr) Procedes et compositions destines a reduire des populations cellulaires specifiques dans du sang et/ou des tissus
GB2360360B (en) A method of sorting cells
WO2007127659A3 (fr) Méthodes et compositions pour la séparation de cellules
WO2002064666A3 (fr) Substrats contenant des polyphosphazenes servant de matrice, et substrats contenant des polyphosphazenes presentant une surface microstructuree
WO2004066937A3 (fr) Anticorps specifiques pour les cellules dendritiques plasmacytoides
AU2003233295A1 (en) Method of decontaminating soil
EP1556404A4 (fr) Antigene p30 genetiquement modifie, combinaison d'antigenes amelioree et utilisations associees
AU2002360791A8 (en) Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
AU2002257064A1 (en) Methods for isolating proteins expressed by dendritic cells
WO2000077251A3 (fr) Dosages biologiques
WO2002097129A3 (fr) Procedes de tri de cellules
AU2002221261A1 (en) Method, antigen and antibody for distinguishing viable and apoptotic cells